Opportunistic infections in HIV: Difference between revisions
From IDWiki
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
|- |
|- |
||
| Any |
| Any |
||
| − | | Tuberculosis |
+ | | [[Tuberculosis]] |
| Screen for latent tuberculosis<br/>Vaccinate for pneumococcus, influenza, varicella, HPV (if appropriate), Hepatitis A, and Hepatitis B |
| Screen for latent tuberculosis<br/>Vaccinate for pneumococcus, influenza, varicella, HPV (if appropriate), Hepatitis A, and Hepatitis B |
||
|- |
|- |
||
| < 500 |
| < 500 |
||
| − | | Kaposi sarcoma (HHV-8)<br/>Herpes simples<br/>Varicella zoster |
+ | | [[Kaposi sarcoma]] (HHV-8)<br/>[[Herpes simples]]<br/>[[Varicella zoster]] |
| |
| |
||
|- |
|- |
||
| < 300 |
| < 300 |
||
| − | | Candida<br/>Molluscum contagiosum<br/>Diarrhea from microsporidia and cryptosporidia |
+ | | [[Candida]]<br/>[[Molluscum contagiosum]]<br/>Diarrhea from [[microsporidia]] and [[cryptosporidia]] |
| |
| |
||
|- |
|- |
||
| < 200 |
| < 200 |
||
| − | | ''Pneumocystis jirovecii'' pneumonia<br/> |
+ | | ''[[Pneumocystis jirovecii]]'' pneumonia<br/>[[Dimorphic fungi]] |
| Start PJP prophylaxis (Septra SS or DS) |
| Start PJP prophylaxis (Septra SS or DS) |
||
|- |
|- |
||
| < 100 |
| < 100 |
||
| − | | Toxoplasmosis<br/>Cryptococcus |
+ | | [[Toxoplasmosis]]<br/>[[Cryptococcus]] |
| Start toxo prophylaxis if IgG positive (Septra DS) |
| Start toxo prophylaxis if IgG positive (Septra DS) |
||
|- |
|- |
||
| < 50 |
| < 50 |
||
| − | | Mycobacterium avium complex |
+ | | [[Mycobacterium avium complex]]<br/>[[Cytomegalovirus]], including retinitis<br/>Progressive multifocal leukoencephalopathy (PML) from [[JC virus]] |
| Start MAC prophylaxis (azithromycin) |
| Start MAC prophylaxis (azithromycin) |
||
|} |
|} |
||
Revision as of 05:37, 16 August 2019
| CD4 | Infections | Action |
|---|---|---|
| Any | Tuberculosis | Screen for latent tuberculosis Vaccinate for pneumococcus, influenza, varicella, HPV (if appropriate), Hepatitis A, and Hepatitis B |
| < 500 | Kaposi sarcoma (HHV-8) Herpes simples Varicella zoster |
|
| < 300 | Candida Molluscum contagiosum Diarrhea from microsporidia and cryptosporidia |
|
| < 200 | Pneumocystis jirovecii pneumonia Dimorphic fungi |
Start PJP prophylaxis (Septra SS or DS) |
| < 100 | Toxoplasmosis Cryptococcus |
Start toxo prophylaxis if IgG positive (Septra DS) |
| < 50 | Mycobacterium avium complex Cytomegalovirus, including retinitis Progressive multifocal leukoencephalopathy (PML) from JC virus |
Start MAC prophylaxis (azithromycin) |
Prophylaxis regimens
- Pneumocystis jirovecii (CD4 <200)
- Preferred: TMP-SMX 1 DS or SS PO daily
- Alternate
- TMP-SMX 1 DS PO three times weekly
- Dapsone 100 mg PO daily or 50 mg PO BID
- Pentamidine nebs 300 mg every month
- Atovaquone 1500 mg PO daily
- Toxoplasma gondii (CD4 <100 and IgG positive)
- Preferred: TMP-SMX 1 DS PO daily
- Alternate
- TMP-SMX 1 DS PO three times weekly
- TMP-SMX 1 SS PO daily
- Dapsone 50 mg PO daily + pyrimethamine/leucovorin PO weekly
- Atovaquone 1500 mg PO daily
- Mycobacterium avium complex (CD4 <50)
- Preferred: Azithromycin 1200 mg PO once weekly
- Alternate
- Clarithromycin 500 mg PO BID
- Azithromycin 600 mg PO twice weekly
- Rifabutin, dose-adjusted to HIV meds
